Philip N. Sussman
Fondateur chez Lesanne Life Sciences LLC
Profil
Philip N.
Sussman is the founder of Lesanne Life Sciences LLC, which was founded in 2006.
He currently holds positions as Director at Thar Pharmaceuticals, Inc. and Chief Financial Officer, Treasurer & Executive VP at Perosphere, Inc. He also worked as Managing Partner at The Channel Group and BioMed Transition Partners.
Mr. Sussman received his undergraduate degree from Stony Brook University and his graduate degree from Manhattan College and MIT Sloan School of Management.
Postes actifs de Philip N. Sussman
| Sociétés | Poste | Début |
|---|---|---|
Thar Pharmaceuticals, Inc.
 Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | Directeur/Membre du Conseil | - |
Perosphere, Inc.
 Perosphere, Inc. Pharmaceuticals: MajorHealth Technology Perosphere, Inc. operates as a pharmaceutical company that focuses on addressing unmet medical needs associated with anticoagulant therapies. Its drug product candidate, ciraparantag, is an intravenously administered small synthetic water soluble new molecular entity rationally designed for use as a broad-spectrum reversal agent for anticoagulants including heparins and the new oral anticoagulants allowing rapid re-establishment of a normal blood coagulation state when clinically indicated. The firm's device product candidate is point-of-care coagulometer, a hand-held device that tests fresh or citrated whole blood. The system is designed for broad-spectrum monitoring of the activity of anticoagulants and their corresponding antidotes, across drug classes, in a hospital setting at a patient's bedside. The company was founded by Sasha H. Bakhru, Edith Mathiowitz, Bryan E. Laulicht and Solomon S. Steiner in 2011 and is headquartered in Danbury, CT. | Directeur Financier/CFO | - |
Lesanne Life Sciences LLC
 Lesanne Life Sciences LLC BiotechnologyHealth Technology Lesanne Life Sciences LLC operates as a stroke diagnostics company. The firm develops diagnostics foe the stroke, traumatic brain injury and CNS ischemia from CABG surgery. The company was founded by Ann H. Cornell-Bell, Leslie A. Riblet, Robert J. Beckman, Allan R. Goldberg and Philip N. Susman in 2006 and is headquartered in Ivoryton, CT. | Fondateur | 01/01/2006 |
Anciens postes connus de Philip N. Sussman
| Sociétés | Poste | Fin |
|---|---|---|
BioMed Transition Partners
 BioMed Transition Partners Miscellaneous Commercial ServicesCommercial Services BioMed Transition Partners provides biomedical management services. The private company is based in New York, NY. The company was founded by Robert J. Beckman. | Corporate Officer/Principal | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Heart Metabolics Ltd.
 Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Directeur Financier/CFO | - |
Axiom Biotechnologies, Inc.
 Axiom Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Axiom Biotechnologies, Inc. discovered and developed drugs through use of its proprietary human cell-based physiogenomics technology and focused on cancer, acid reflux disease, and obesity. The company was headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Formation de Philip N. Sussman
| Manhattan College | Graduate Degree |
| Stony Brook University | Undergraduate Degree |
| MIT Sloan School of Management | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHARMAROTH LABS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 13 |
|---|---|
The Channel Group
 The Channel Group Investment ManagersFinance The Channel Group is a venture management and corporate advisory business headquartered in Harrison, New York. | Finance |
Thar Pharmaceuticals, Inc.
Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA. | Health Technology |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Health Technology |
Cadus Corp.
 Cadus Corp. BiotechnologyHealth Technology Cadus Corp. engages in the acquisition, renovation and construction of real estate. It intends to purchase individual homes or individual residential lots for purposes of renovation or construction and resale. The company was founded by Dana M. Fowlkes, James R. Broach, and Thomas Shenk on January 23, 1992 and is headquartered in New York, NY. | Health Technology |
Lesanne Life Sciences LLC
Lesanne Life Sciences LLC BiotechnologyHealth Technology Lesanne Life Sciences LLC operates as a stroke diagnostics company. The firm develops diagnostics foe the stroke, traumatic brain injury and CNS ischemia from CABG surgery. The company was founded by Ann H. Cornell-Bell, Leslie A. Riblet, Robert J. Beckman, Allan R. Goldberg and Philip N. Susman in 2006 and is headquartered in Ivoryton, CT. | Health Technology |
| LCT Biopharma, Inc. | |
Axiom Biotechnologies, Inc.
Axiom Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Axiom Biotechnologies, Inc. discovered and developed drugs through use of its proprietary human cell-based physiogenomics technology and focused on cancer, acid reflux disease, and obesity. The company was headquartered in San Diego, CA. | Commercial Services |
Phage Pharmaceuticals, Inc.
 Phage Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Phage Pharmaceuticals, Inc. manufactures therapeutic protein which makes use of a proprietary production method that improves upon well-established approaches for the manufacture of proteins and results in the production of simple, properly folded therapeutic proteins at high yields. The company was founded in 1998 and is headquartered in San Diego, CA. | Health Technology |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Perosphere, Inc.
Perosphere, Inc. Pharmaceuticals: MajorHealth Technology Perosphere, Inc. operates as a pharmaceutical company that focuses on addressing unmet medical needs associated with anticoagulant therapies. Its drug product candidate, ciraparantag, is an intravenously administered small synthetic water soluble new molecular entity rationally designed for use as a broad-spectrum reversal agent for anticoagulants including heparins and the new oral anticoagulants allowing rapid re-establishment of a normal blood coagulation state when clinically indicated. The firm's device product candidate is point-of-care coagulometer, a hand-held device that tests fresh or citrated whole blood. The system is designed for broad-spectrum monitoring of the activity of anticoagulants and their corresponding antidotes, across drug classes, in a hospital setting at a patient's bedside. The company was founded by Sasha H. Bakhru, Edith Mathiowitz, Bryan E. Laulicht and Solomon S. Steiner in 2011 and is headquartered in Danbury, CT. | Health Technology |
BioMed Transition Partners
BioMed Transition Partners Miscellaneous Commercial ServicesCommercial Services BioMed Transition Partners provides biomedical management services. The private company is based in New York, NY. The company was founded by Robert J. Beckman. | Commercial Services |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
